The examination of effectiveness and safety ofEfinaconazole

The examination of effectiveness and safety ofEfinaconazole - The examination of effectiveness and safety ofEfinaconazole

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000036350

Enrollment

Registered

2019-03-29

Start date

2015-07-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tinea unguium

Interventions

For tinea unguium, Efinaconazole nail external use medicine is applied externally 1 time per day until cures.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Tinea unguium of the first digit nail of the foot

Exclusion criteria

Exclusion criteria: 1.The patient with the medical history of the hypersensitivity for the component of this medicine 2.Pregnant woman and patient with the pregnant possibility or patient with lactation 3.The patient who participated in other clinical trial within 4 months 4.The in addition, patient who it judged with the inappropriateness, as the research responsible person made it to be an examinee.

Design outcomes

Primary

Measure	Time frame
The turbidity ratio of the nail	—

Countries

Japan

Contacts

Public Contactmotoi takenaka

Nagasaki University Hospital Department of Dermatoallergology

m-take@nagasaki-u.ac.jp095-819-7333

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026